{"disease":{"id":"columnar-cell-variant-thyroid-gland-papillary-carcinoma","name":"columnar cell variant thyroid gland papillary carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02973997","title":"Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}